BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...
The gross proceeds from the offering are expected to be approximately $3.13 million, excluding any proceeds that may be received upon exercise of the warrants and before deducting the placement ...
SAN ANTONIO, October 21, 2024--bioAffinity Technologies announces closing of $2.6 million registered direct offering and ...
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company ...
Detailed price information for Ascot Resources Ltd (AOT-T) from The Globe and Mail including charting and trades.
Aldel Financial II Inc. (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chairman and CEO Robert Kauffman (former ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Rio2 Limited ("Rio2" or the "Company") ...
1h
In May 2024, Kincora signed a definitive multiple-phase Earn-in and Joint Venture Agreement over the Nyngan and Nevertire ...
Bannix Acquisition Corp. ('Bannix”) announced today that its board of directors (the 'Board”) has decided to extend the date by which Bannix must consummate an initial business combination (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback